Skip to main content

Prevalence of Recreational Drug Use 11 Percent in Cardiac ICUs

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Aug. 18, 2023 -- For patients hospitalized in intensive cardiac care units (ICCUs), the prevalence of recreational drug use is 11 percent, according to a study published online Aug. 15 in Heart.

Théo Pezel, M.D., from Université Paris Cité, and colleagues examined the prevalence of recreational drug use and its association with in-hospital major adverse events (MAEs) in patients admitted to the ICCU. All patients admitted to the ICCU in 39 French centers from April 7 to 22, 2021, underwent systematic screening for recreational drugs performed by prospective urinary testing.

The researchers found that 11 percent of 1,499 consecutive patients had a positive test for recreational drugs (cannabis, 9.1 percent; opioids, 2.1 percent; cocaine, 1.7 percent; amphetamines, 0.7 percent; 3,4-methylened ioxymethamphetamine [MDMA], 0.6 percent). Recreational drug use was declared by 57 percent of these patients. Those using recreational drugs had a higher rate of MAEs (13 versus 3 percent). After adjustment for comorbidities, recreational drugs were associated with a higher rate of in-hospital MAEs (odds ratio, 8.84). Cannabis, cocaine, and MDMA, assessed separately, were independently associated with in-hospital MAEs, after adjustment. Twenty-eight percent of positive patients had multiple drug detection, which was associated with even higher incidence of MAEs (odds ratio, 12.7).

"The detection of recreational drug use was a strong and robust independent predictor of MAE," the authors write. "Multiple recreational drugs users had the worst in-hospital prognosis, with a doubling of MAE risk, compared with single-drug users."

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.